Conversely, blockade of lactate production via inhibition of pyruvate dehydrogenase with oxamate led to increased CD8+ T cell infiltration, reduced NSCLC tumor growth and improved responses to anti-PD-1 antibodies [99]. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.